Congratulations Longs! "We are fortunate that our shareholders saw the value proposition in the company to invest at a level that enables us to once again qualify to use this source of capital. Small biotech companies often run out of money before their products even get a chance to succeed, and this funding opportunity goes a long way in minimizing that possibility..." KW
Getting CiaB to patients is of utmost importance...
"Waggoner said that the one thing he's constantly thinking about is the infinite possibilities for his company's platform technology Cell-in-a-Box® to treat so many forms of solid tumor cancers -- liver, breast, ovarian -- to name a few."
News 
Market Data 
Discover 
